Literature DB >> 6209787

Secondary immunization with a protein antigen (tetanus toxoid) in man. Characterization of humoral and cell-mediated regulatory events.

A D Donnenberg, G J Elfenbein, G W Santos.   

Abstract

Tetanus toxoid (TET) was used as an immunogen to explore regulatory events occurring after secondary immunization in man. Changes in dose-response patterns, kinetics, and frequency of antigen-reactive cells in the peripheral blood, and the serum antibody titres were studied. The most striking feature of these studies was the finding that immediately after immunization, a brief period of decreased responsiveness preceded the expected amplification of antigen-specific humoral and cell-mediated responses. One day after immunization serum antibody levels declined to approximately half their initial values before the expected increase in titre. These results could not be explained by the formation of antigen-antibody complexes. Lymphoproliferative responses were also depressed 1 day after immunization but increased in both magnitude and sensitivity from 7 to 28 days after challenge. A decrease in thymidine incorporation evident at supraoptimal antigen concentrations also became progressively more prominent during this interval. Cell mixing experiments documented the presence of a radioresistant population present 1 day after immunization capable of suppressing TET-specific lymphoproliferative responses of autologous lymphocytes obtained before immunization. These suppressors are preferentially activated at high antigen concentrations. Limiting dilution analysis revealed a 30-fold increase in TET-reactive proliferating cells by 28 days after immunization. Expansion occurred first in cells recognizing high antigen concentrations and subsequently in cells recognizing lower doses. Taken together, these findings present a consistent if somewhat counterintuitive picture of some of the regulatory processes accompanying booster immunization. The earliest detectable event appears to be the application of an active suppressor mechanism, release from which signals initiation of those processes classically associated with an anamnestic response.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6209787     DOI: 10.1111/j.1365-3083.1984.tb01004.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  5 in total

1.  Effect of donor and recipient immunization protocols on primary and secondary human antibody responses in SCID mice reconstituted with human peripheral blood mononuclear cells.

Authors:  R B Markham; A D Donnenberg
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

2.  Therapeutic efficacy of a conjugate vaccine containing a peptide mimotope of cryptococcal capsular polysaccharide glucuronoxylomannan.

Authors:  Kausik Datta; Andrew Lees; Liise-anne Pirofski
Journal:  Clin Vaccine Immunol       Date:  2008-06-04

3.  Appearance of IgG and IgA antibodies in human bile after tetanus toxoid immunization.

Authors:  P G Hansen; E J Hennessy; H Blake; R L Clancy; R Kamath; C Molenaar; A W Cripps; G D Jackson
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

4.  Sex, Age, and Ethnic Background Shape Adaptive Immune Responses Induced by the SARS-CoV-2 mRNA Vaccine.

Authors:  Jie Bai; Asako Chiba; Goh Murayama; Taiga Kuga; Naoto Tamura; Sachiko Miyake
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

5.  Vaccination Expands Antigen-Specific CD4+ Memory T Cells and Mobilizes Bystander Central Memory T Cells.

Authors:  Eleonora Li Causi; Suraj C Parikh; Lindsey Chudley; David M Layfield; Christian H Ottensmeier; Freda K Stevenson; Gianfranco Di Genova
Journal:  PLoS One       Date:  2015-09-02       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.